GHK-Cu vs BPC-157: A Research Comparison
Two research peptides that are often confused, set side by side. What each compound is, what each is studied for, how they differ in structure and origin, and why both appear together in the GLOW blend. Research use only.
GHK-Cu vs BPC-157 at a Glance
GHK-Cu and BPC-157 are both research peptides, but they are different molecules studied for different research interests. GHK-Cu is a naturally occurring copper-binding tripeptide (three amino acids plus a copper ion) investigated mainly in skin, collagen and regeneration research. BPC-157 is a synthetic 15-amino-acid pentadecapeptide studied mainly in soft-tissue and gastrointestinal tissue-repair research. They are not interchangeable, and both appear together in the GLOW blend.
This page is general educational information for laboratory and research audiences. Neither GHK-Cu nor BPC-157 is approved by the TGA for human therapeutic use, and nothing here is medical, legal or dosing advice. All language is research-framed, and these compounds have not been assessed by the TGA for safety, quality or efficacy in this context.
GHK-Cu vs BPC-157: Side-by-Side Comparison
| Attribute | GHK-Cu | BPC-157 |
|---|---|---|
| Compound type | Naturally occurring copper-binding tripeptide | Synthetic pentadecapeptide |
| Amino acids | 3 (glycine, histidine, lysine) plus a bound copper ion | 15 (pentadecapeptide) |
| Sequence | Glycyl-L-histidyl-L-lysine, chelated to copper (Cu) to form GHK-Cu | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Occurs naturally in the human body and has been identified in human plasma | Partial sequence of a body-protection compound found in human gastric juice |
| Primary research focus | Skin remodelling, collagen synthesis, wound-healing and regeneration research | Soft-tissue (muscle, tendon, ligament, bone) and gastrointestinal repair research |
| Proposed role | Studied as a signal and carrier peptide; copper as an enzyme cofactor | Studied for angiogenesis, growth-factor signalling and fibroblast activity |
| Research framing | Often described in skin and cosmetic-regeneration contexts | Often described in localised connective-tissue and gut contexts |
| Appears together in | GLOW blend and KLOW blend | GLOW blend and KLOW blend |
| AU regulatory status | Not scheduled under the Poisons Standard; research use only | Schedule 4 and Appendix D since 1 June 2024; TGA-unapproved, research use only |
What Is GHK-Cu?
GHK-Cu is a copper-binding tripeptide, which means it is a very short chain of three amino acids, glycine, histidine and lysine (glycyl-L-histidyl-L-lysine), bound to a copper ion to form the GHK-Cu chelate. It is a naturally occurring molecule rather than a wholly synthetic construct, and it has been identified as an activity in human plasma.
In the research literature, GHK-Cu has been studied largely in skin, collagen and regeneration contexts. Researchers describe it as a signal or carrier peptide, with the copper component acting as a cofactor for enzymes involved in collagen cross-linking, such as lysyl oxidase. It has also been investigated for its effects on growth factors in fibroblasts and on gene-expression, collagen and wound-healing pathways.
GHK is reported in the research literature as a molecule whose plasma levels tend to decline with age. This is described as an age-related observation in the literature, not a claim about any product or outcome.
GHK-Cu research highlights
- A naturally occurring tripeptide, glycine-histidine-lysine, chelated to copper
- Studied largely in skin, collagen-synthesis and regeneration research
- Described as a signal or carrier peptide, with copper as an enzyme cofactor
- Investigated for effects on growth factors in fibroblasts and on gene-expression pathways
What Is BPC-157?
BPC-157 is a synthetic pentadecapeptide, meaning a chain of 15 amino acids. Its name stands for Body Protection Compound 157, because the sequence is based on a partial fragment of a body-protection compound identified in human gastric juice. Unlike GHK-Cu, it is produced synthetically rather than isolated as a naturally circulating molecule.
In preclinical and animal research, BPC-157 is studied mainly in tissue-repair contexts spanning muscle, tendon, ligament, bone and gastrointestinal tissue. The literature describes investigated effects on angiogenesis (new blood-vessel formation), collagen synthesis, fibroblast activity and nitric-oxide pathways. Human research is limited, so research framing is essential when discussing it.
The cleanest way to keep these two apart is by structure and focus. GHK-Cu is a 3-amino-acid copper tripeptide, naturally occurring, studied largely in skin and collagen research. BPC-157 is a 15-amino-acid synthetic pentadecapeptide, gastric-derived, studied largely in soft-tissue and gastrointestinal repair research.
How They Differ: Structure, Origin and Research Focus
The first difference is size and structure. GHK-Cu is a tripeptide, three amino acids carrying a copper ion, while BPC-157 is a pentadecapeptide, fifteen amino acids with no metal cofactor. That copper ion is central to how GHK-Cu is described in the literature, whereas BPC-157 is studied as a peptide sequence in its own right.
The second difference is origin. GHK-Cu occurs naturally in the human body and has been identified in human plasma. BPC-157 is synthetic, modelled on a fragment of a body-protection compound found in gastric juice. The third difference is research focus: GHK-Cu research clusters around skin, collagen and regeneration, while BPC-157 research clusters around soft-tissue and gastrointestinal repair.
The split, at a glance
- Structure: GHK-Cu is a 3-amino-acid copper tripeptide; BPC-157 is a 15-amino-acid pentadecapeptide
- Origin: GHK-Cu occurs naturally in plasma; BPC-157 is synthetic, based on a gastric compound
- Research focus: GHK-Cu in skin and collagen contexts; BPC-157 in soft-tissue and gut contexts
- Regulatory status: GHK-Cu is not scheduled in Australia; BPC-157 is Schedule 4 and Appendix D
Which Is Better, GHK-Cu or BPC-157?
This is the question most searchers arrive with, and the honest research answer is that it is not a contest between two interchangeable options. The two are different molecules studied for different research interests, so framing one as universally superior misrepresents the literature. We cannot and do not recommend either for any individual, body or purpose, because that would cross into medical advice.
What the research does support is a clear distinction of focus. If a research interest is skin, collagen synthesis and cosmetic-regeneration, GHK-Cu is the compound that body of work centres on. If the interest is soft-tissue and gastrointestinal repair, BPC-157 is where that research sits. Because the two are studied along different pathways rather than competing ones, they are sometimes formulated together rather than chosen one over the other.
The most useful answer to GHK-Cu vs BPC-157 is not a winner. It is the recognition that the two are different molecules studied for different research interests, skin and collagen versus soft-tissue and gut, which is why they can appear in the same blend.
The GLOW Blend: Where GHK-Cu and BPC-157 Appear Together
GHK-Cu and BPC-157 are not only studied separately. They co-appear in the GLOW blend, a single research vial that combines GHK-Cu, BPC-157 and TB-500. They also appear together in the KLOW blend, which adds KPV to the same three. This is the natural place where researchers encounter both compounds in one documented package.
We do not provide dosing, reconstitution, frequency or stacking protocols, and the GLOW blend should be understood here as a research formulation that contains both peptides, not a usage instruction or a benefit guarantee. The point is simply that the two compounds discussed on this page are combined in a single, lab-tested research product.
Every GLOW and KLOW vial ships with a third-party Janoshik Certificate of Analysis for independent verification, alongside Australian shipping. These assay reports are lab-verification values, not dosing recommendations. Enquiries are handled directly over WhatsApp, with no cart or prices attached, and the kits are supplied for research use only.
Third-party Janoshik Certificate of Analysis (COA)
Legal and Regulatory Status in Australia
This section is general information only and is not legal or medical advice. The regulatory status of these two compounds is one of the clearest differences between them. GHK-Cu is not a scheduled substance under the Poisons Standard. It is widely used as a cosmetic ingredient, though making therapeutic claims about it would bring a product under TGA and ARTG oversight.
BPC-157 is treated very differently. It was added to Schedule 4 (Prescription Only) and to Appendix D of the Poisons Standard, with effect from 1 June 2024. BPC-157 is not approved by the TGA for human therapeutic use and is supplied for research use only.
BPC-157 is prohibited in sport under WADA and Sport Integrity Australia, in the peptide class, and is prohibited at all times. Athletes subject to anti-doping rules should treat it accordingly. We describe this status neutrally and do not advise on how to obtain, import or use any scheduled compound.
For a fuller breakdown of the research-use-only framework and how NovaPeptides handles sourcing and lab testing, see the research-use-only and sourcing guides linked below. Both peptides are supplied for research use only and have not been assessed by the TGA for safety, quality or efficacy in this context.
Frequently asked questions
What is the difference between GHK-Cu and BPC-157?+
GHK-Cu is a naturally occurring copper-binding tripeptide (three amino acids plus a copper ion) studied mainly in skin, collagen and regeneration research. BPC-157 is a synthetic 15-amino-acid pentadecapeptide based on a gastric body-protection compound, studied mainly in soft-tissue and gastrointestinal repair research. They are different molecules studied for different research interests, not interchangeable substitutes.
Is GHK-Cu or BPC-157 better?+
Neither is universally better, because they are studied for different research interests. GHK-Cu research centres on skin and collagen, while BPC-157 research centres on soft-tissue and gut repair. We cannot recommend either for any person or purpose, as that would be medical advice. The more useful framing is that they target different research pathways, which is why both can appear in the same blend.
Can GHK-Cu and BPC-157 be used together?+
In research formulations they already appear together. Both GHK-Cu and BPC-157 are present in the GLOW blend (alongside TB-500) and in the KLOW blend (which also adds KPV). We do not provide dosing, reconstitution or stacking protocols, and the blends should be understood as research formulations that contain both peptides, not usage instructions.
What is the GLOW peptide blend made of?+
The GLOW blend combines GHK-Cu, BPC-157 and TB-500 in a single research vial. Every kit ships with a third-party Janoshik Certificate of Analysis for independent verification. The assay figures on each report are lab-verification values, not dosing recommendations.
Is GHK-Cu legal in Australia?+
GHK-Cu is not a scheduled substance under the Poisons Standard, unlike BPC-157. It is widely used as a cosmetic ingredient, though making therapeutic claims about it would bring a product under TGA and ARTG oversight. NovaPeptides supplies it for research use only, and this is general information rather than legal advice.
Is BPC-157 legal in Australia?+
BPC-157 was added to Schedule 4 (Prescription Only) and to Appendix D of the Poisons Standard, with effect from 1 June 2024. It is not approved by the TGA for human therapeutic use and is also prohibited in sport under WADA. It is supplied for research use only.
Does NovaPeptides supply GHK-Cu and BPC-157 together?+
Yes. Both compounds appear together in the GLOW blend (GHK-Cu, BPC-157 and TB-500) and in the KLOW blend (which also includes KPV). Every kit ships with a third-party Janoshik Certificate of Analysis and Australian shipping. Enquiries are handled over WhatsApp, with no cart or prices, and the kits are supplied for research use only.
Questions? Talk to us.
Message us on WhatsApp and we will walk you through the kits, the COAs, reconstitution and the dose tool.
Chat with us on WhatsApp